- Research works
- 74 ▲ 96% vs 2013–17
- Citations
- 913 12.3 per fractional work
- Top-10% rate
- 19.2% record average 16.5%
- Open access
- 48% world 28%
Not ranked overall: Bladder Cancer Advocacy Network is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.
Which keywords describe research at Bladder Cancer Advocacy Network?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Molecular Characterization, Neoadjuvant Therapy, Guidelines, Bladder Cancer, Urothelial Carcinoma and Epidemiology.
- Tumor Microenvironment
- Urotrauma
- Primary Urethral Carcinoma
- Epidemiology
- Guidelines
- Neoadjuvant Therapy
- Chemotherapy
- Immunotherapy
- Molecular Characterization
- Bladder Cancer
- Urothelial Carcinoma
- Genitourinary Development
- Urachal Carcinoma
- Quality of Life
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 14 words, with their numbers
- Immunotherapy7▲ 43×6 topics
- Chemotherapy7▲ 43×7 topics
- Molecular Characterization6▲ 165×3 topics
- Neoadjuvant Therapy6▲ 122×3 topics
- Bladder Cancer6▲ 736×1 topic
- Guidelines6▲ 60×2 topics
- Urothelial Carcinoma6▲ 637×1 topic
- Epidemiology3▲ 3.3×8 topics
- Genitourinary Development2▲ 252×1 topic
- Primary Urethral Carcinoma2▲ 470×1 topic
- Urachal Carcinoma2▲ 470×1 topic
- Urotrauma2▲ 252×1 topic
- Quality of Life2▲ 5.3×8 topics
- Tumor Microenvironment1▲ 12×5 topics
Which research topics does Bladder Cancer Advocacy Network publish most on?
By volume in 2022–2025: Bladder and Urothelial Cancer Treatments, Urological Disorders and Treatments, Urinary and Genital Oncology Studies and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Bladder and Urothelial Cancer Treatments Surgery 6 works
- 2 Urological Disorders and Treatments Urology 2 works
- 3 Urinary and Genital Oncology Studies Surgery 2 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 5 Cancer survivorship and care Oncology 0 works
- 6 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 0 works
- 7 Urinary Bladder and Prostate Research Urology 0 works
- 8 Pelvic floor disorders treatments Rheumatology 0 works
- 9 Urinary Tract Infections Management Epidemiology 0 works
- 10 Patient-Provider Communication in Healthcare General Health Professions 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Bladder Cancer Advocacy Network's research output changed?
Output in 2018–2022 was 96% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Bethesda
- National Institutes of Health
- National Cancer Institute
- Uniformed Services University of the Health Sciences
- National Institute of Allergy and Infectious Diseases
- Lockheed Martin (United States)
- National Heart Lung and Blood Institute
- National Institute of Mental Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.